Evidence map›Paper›PMID 35187434›Full record

ArticleBeyoglu eye journal2019

Evaluation of Retinol Palmitate Treatment of Photokeratitis in Rat Eyes Exposed to Ultraviolet B Radiation.

Mehmet Caner Filizay, Nesrin Buyuktortop Gokcinar, Varol Sahinturk, Setenay Oner, Sedat Kacar, Zafer Onaran, Erhan Yumusak

Open access · diamondAbstract read
In one paragraph

Article in Beyoglu eye journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mehmet Caner FilizayDepartment of Ophthalmology, Eskisehir State Hospital, Eskisehir, Turkey.
Nesrin Buyuktortop GokcinarDepartment of Ophthalmology, Kirikkale University Faculty of Medicine, Kirikkale, Turkey.
Varol SahinturkDepartment of Histology and Embryology, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
Setenay OnerDepartment of Biostatistics, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
Sedat KacarDepartment of Histology and Embryology, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
Zafer OnaranDepartment of Ophthalmology, Kirikkale University Faculty of Medicine, Kirikkale, Turkey.
Erhan YumusakDepartment of Ophthalmology, Kirikkale University Faculty of Medicine, Kirikkale, Turkey.
Eskişehir City Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAcute exposure to ultraviolet B radiation can cause photokeratitis. Retinol palmitate (RP) is known to have antioxidant properties and improve corneal healing. The aim of this study was to evaluate the effect of topical RP against phototoxic keratitis in rats.

methodsA total of 14 male Wistar Albino rats were exposed to 1 J/cm

resultsThere was no statistically significant difference between the mean corneal epithelial thickness of the RP-5 group and the Sham-5 group (p=0.369). Furthermore, there was no significant difference between the RP-120 and the Sham-120 groups (p=0.765). The timing of the administration of RP resulted in no significant difference in the mean corneal epithelial thickness (p=0.608). Apoptotic cell count scores were not significantly different between corneas that received RP and those who received only the vehicle (p=0.530, p=0.107).

conclusionTopical administration of a single dose of RP was not superior to the use of the vehicle base alone in a photokeratitis model produced using 1 J/cm

Indexed as

Apoptosiscorneaphotokeratitisretinol palmitateultravioletvitamin A

Identifiers

PMID35187434
PMCPMC8842044
OpenAlexW2953189892

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.